Claims
- 1. An N.sup.2 -arlysulfonyl-L-argininamide having the formula (I): ##STR810## or a pharmaceutically acceptable salt thereof, wherein R is ##STR811## wherein R.sub.1 is furfuryl, 3-furylmethyl, tetrahydrofurfuryl or tetrahydro-3-furylmethyl; R.sub.2 is hydrogen, C.sub.1 - C.sub.10 alkyl, carboxy, C.sub.2 - C.sub.10 alkoxycarbonyl, phenyl optionally substituted with one or more C.sub.1 - C.sub.5 alkyl, C.sub.1 - C.sub.5 alkoxy or mixtures thereof, C.sub.7 - C.sub.12 aralkyl or ring substituted benzyl wherein said substituent is C.sub.1 - C.sub.5 alkyl or C.sub.1 - C.sub.5 alkoxy; R.sub.3 is hydrogen, C.sub.1 - C.sub.10 alkyl, C.sub.6 - C.sub.10 aryl, C.sub.7 - C.sub.12 aralkyl or 5-indanyl; and n is o, 1 or 2, ##STR812## where in R.sub.4 is hydrogen, C.sub.1 - C.sub.10 alkyl, C.sub.6 - C.sub.10 aryl, C.sub.7 - C.sub.12 aralkyl or 5-indanyl; Z is oxy, thio or sulfinyl; and m is 0 or 1, or ##STR813## wherein R.sub.5 is hydrogen, C.sub.1 - C.sub.10 alkyl, C.sub.6 - C.sub.10 aryl, C.sub.7 - C.sub.12 aralkyl or 5-indanyl; p is 0, 1 or 2; q is 0, 1 or 2: and p + q is 1 or 2:
- and Ar is naphthyl substituted with at least one substituent selected from the group consisting of halo, hydroxy, nitro, cyano, C.sub.1 - C.sub.10 alkyl, C.sub.1 - C.sub.10 alkoxy and C.sub.2 - C.sub.20 dialkyamino, and at least one substituent selected from the group consisting of sulfoamino, carbamoyl, C.sub.3 - C.sub.10 N,N-dialkylcarbamoyl, amino, C.sub.1 - C.sub.10 alkylamino, mercapto, C.sub.1 - C.sub.10 alkylthio, C.sub.7 - C.sub.12 aralkyl, carboxyl, C.sub.2 - C.sub.10 alkoxycarbonyl, C.sub.2 - C.sub.10 carboxyalkyl, C.sub.1 - C.sub.10 acylamino, C.sub.2 - C.sub.10 alkylcarbonyl, C.sub.1 - C.sub.10 hydroxyalkyl, C.sub.1 - C.sub.10 haloalkyl and phenyl optionally substituted with at least one hydroxy C.sub.1 - C.sub.5 alkoxy or mixtures thereof, naphthyl substituted with at least one substituent selected from the group consisting of sulfoamino, carbamoyl, C.sub.3 - C.sub.10 N,N-dialkylcarbamoyl, amino, C.sub.1 - C.sub.10 alkylamino, mercapto, C.sub.1 - C.sub.10 alkylthio, C.sub.7 - C.sub.12 aralkyl, carboxyl, C.sub.2 - C.sub.10 alkoxycarbonyl, C.sub.2 - C.sub.10 carboxyalkyl, C.sub.1 - C.sub.10 acylamino, C.sub.2 - C.sub.10 alkylcarbonyl, C.sub.1 - C.sub.10 hydroxyalkyl, C.sub.1 - C.sub.10 haloalkyl and phenyl optionally substituted with at least one hydroxy, C.sub.1 - C.sub.5 alkoxy or mixtures thereof;
- 5. 6,7,8-tetrahydronaphthyl substituted with at least one substituent selected from the group consisting of halo, nitro, cyano, hydroxy, C.sub.1 - C.sub.10 alkyl, C.sub.1 - C.sub.10 alkoxy, sulfoamino carbamoyl, C.sub.3 - C.sub.10 N,N-diakylcarbamoyl, amino, C.sub.1 - C.sub.10 alkylamino, mercapto, C.sub.1 - C.sub.10 alkylthio, C.sub.7 - C.sub.12 arakyl, carboxyl, C.sub.2 - C.sub.10 alkoxycarbonyl, C.sub.2 - C.sub.10 carboxyalkyl, C.sub.1 - C.sub.10 acylamino, C.sub.2 - C.sub.10 alkylcarbonyl, C.sub.1 -C.sub.10 hydroxyalkyl, C.sub.1 - C.sub.10 haloaklyl, oxo, and phenyl optionally substituted with at least one hydroxy; C.sub.1 - C.sub.5 alkoxy or mixtures thereof;
- naphthoquinonyl, anthyrl, phenanthryl, pentalenyl, heptalenyl, azulenyl, biphenylenyl, .alpha.s - indacenyl, S-indacenyl, acenaphthylenyl, phenylcarbonylphenyl, phenoxyphenyl, benzofurayl, isobenzofuranyl, benzo �b! thienyl, isobenzothienyl oxanthrenyl, thianthrenyl, dibenzofuranyl, dibenzothienyl, phenoxathiinyl, indolyl, 1H-indazolyl, quinolyl, isoquinolyl, phthalazinyl, 1,8-naphthyridinyl, quinoxalinyl, quinazolinyl, cinnolinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, phenoxazinyl or benzimidazolyl group any of which is unsubstituted or substituted with one or more groups selected from the group consisting of halo, nitro, cyano, hydroxy, C.sub.1 - C.sub.10 alkyl, C.sub.1 - C.sub.10 alkoxy, C.sub.2 - C.sub.20 dialkylamino, sulfoamino carbamoyl, C.sub.3 - C.sub.10 N,N-dialkylcarbamoyl, amino, C.sub.1 - C.sub.10 alkylamino, mercapto, C.sub.1 - C.sub.10 alkylthio, C.sub.7 - C.sub.12 aralkyl, carboxyl, C.sub.2 - C.sub.10 alkoxycarbonyl, C.sub.2 - C.sub.10 carboxyalkyl, C.sub.1 - C.sub.10 acylamino, C.sub.2 - C.sub.10 alkylcarbonyl, C.sub.1 - C.sub.10 hydroxyalkyl, C.sub.1 - C.sub.10 haloalkyl and phenyl optionally substituted with at least one hydroxy C.sub.1 - C.sub.5 alkoxy or mixtures thereof.
- 2. An N.sup.2 -arlysulfonyl-L-argininamide having the formula (I): ##STR814## or a pharmaceutically acceptable salt thereof, wherein R is ##STR815## wherein R.sub.1 is furfuryl, 3-furylmethyl, tetrahydrofurfuryl or tetrahydro-3-furylmethyl; R.sub.2 is hydrogen, C.sub.1 - C.sub.10 alkyl, carboxy, C.sub.2 - C.sub.10 alkoxycarbonyl, phenyl optionally substituted with one or more C.sub.1 - C.sub.5 alkyl, C.sub.1 - C.sub.5 alkoxy or mixtures thereof, C.sub.7 - C.sub.12 aralkyl or ring substituted benzyl wherein said substituent is C.sub.1 - C.sub.5 alkyl or C.sub.1 - C.sub.5 alkoxy; R.sub.3 is hydrogen, C.sub.1 - C.sub.10 alkyl, C.sub.6 - C.sub.10 aryl, C.sub.7 - C.sub.12 aralkyl or 5-indanyl; and n is o, 1 or 2, ##STR816## where in R.sub.4 is hydrogen, C.sub.1 - C.sub.10 alkyl, C.sub.6 - C.sub.10 aryl, C.sub.7 - C.sub.12 aralkyl or 5-indanyl;
- Z is oxy, thio or sulfinyl; and m is 0 or 1, or ##STR817## wherein R.sub.5 is hydrogen, C.sub.1 - C.sub.10 alkyl, C.sub.6 - C.sub.10 aryl, C.sub.7 - C.sub.12 aralkyl or 5-indanyl; p is 0, 1 or 2; q is 0, 1 or 2: and p + q is 1 or 2:
- and Ar is naphthyl subsituted with at least one subsituent selected from the group consisting of halo, hydroxy, nitro, cyano, C.sub.1 - C.sub.10 alkyl, C.sub.1 - C.sub.20 dialkyamino, and at least one subsituent selected from the group consisting of sulfoamino, carbamoyl, C.sub.3 - C.sub.10 N,N-dialkylcarbamoyl, amino, C.sub.1 - C.sub.10 alkylamino, mercapto, C.sub.1 - C.sub.10 alkylthio, C.sub.7 - C.sub.12 aralkyl, carboxyl, C.sub.2 - C.sub.10 alkoxycarbonyl, C.sub.2 - C.sub.10 carboxyalkyl, C.sub.1 - C.sub.10 acylamino, C.sub.2 - C.sub.10 alkylcarbonyl, C.sub.1 - C.sub.10 hydroxyalkyl, C.sub.1 - C.sub.10 haloalkyl and phenyl optionally substituted with at least one hydroxy C.sub.1 - C.sub.5 alkoxy or mixtures thereof, naphthyl substituted with at least one substituent selected from the group consisting of sulfoamino, carbamoyl, C.sub.3 - C.sub.10 N,N-dialkylcarbamoyl, amino, C.sub.1 - C.sub.10 alkylamino, mercapto, C.sub.1 - C.sub.10 alkylthio, C.sub.7 - C.sub.12 aralkyl, carboxyl, C.sub.2 - C.sub.10 alkoxycarbonyl, C.sub.2 - C.sub.10 carboxyalkyl, C.sub.1 - C.sub.10 acylamino, C.sub.2 - C.sub.10 alkylcarbonyl, C.sub.1 - C.sub.10 hydroxyalkyl, C.sub.1 - C.sub.10 haloalkyl and phenyl optionally subsituted with at least one hydroxy, C.sub.1 - C.sub.5 alkoxy or mixtures thereof;
- 5. 6,7,8-tetrahydronaphthyl substituted with at least one substituent selected from the group consisting of halo, nitro, cyano, hydroxy, C.sub.1 - C.sub.10 alkyl, C.sub.1 - C.sub.10 alkoxy, sulfoamino carbamoyl, C.sub.3 - C.sub.10 N,N-diakylcarbamoyl, amino, C.sub.1 - C.sub.10 alkylamino, mercapto, C.sub.1 - C.sub.10 alkylthio, C.sub.7 - C.sub.12 arakyl, carboxyl, C.sub.2 - C.sub.10 alkoxycarbonyl, C.sub.2 - C.sub.10 carboxyalkyl, C.sub.1 - C.sub.10 acylamino, C.sub.2 - C.sub.10 alkylcarbonyl, C.sub.1 - C.sub.10 hydroxyalkyl, C.sub.1 - C.sub.10 haloaklyl, oxo, and phenyl optionally substituted with at least one hydroxy; C.sub.1 - C.sub.5 alkoxy or mixtures thereof:
- a phenyl, naphthyl, which is unsubstituted or substituted with one or more groups selected from the group consisting of halo, nitro, cyano, hydroxy, C.sub.1 - C.sub.10 alkyl, C.sub.1 - C.sub.10 alkoxy, C.sub.2 - C.sub.20 dialkylamino, sulfoamino, carbamoyl, C.sub.3 - C.sub.10 N,N-dialkylcarbamoyl, amino, C.sub.1 - C.sub.10 alkylamino, mercapto, C.sub.1 - C.sub.10 alkylthio, C.sub.7 - C.sub.12 aralkyl, carboxyl, C.sub.2 - C.sub.10 alkoxycarbonyl, C.sub.2 - C.sub.10 carboxyalkyl, C.sub.1 - C.sub.10 acylamino, C.sub.2 - C.sub.10 alkylcarbonyl, C.sub.1 - C.sub.10 hydroxyalkyl, C.sub.1 - C.sub.10 haloalkyl and phenyl optionally substituted with at least on hydroxy, C.sub.1 - C.sub.5 alkoxy or mixtures thereof.
- 3. The compound of claim 1 wherein said Ar groups is substituted with at least one C.sub.1 - C.sub.5 alkoxy, C.sub.1 - C.sub.5 alkyl groups or mixtures thereof.
- 4. The compound of claim 2 wherein said Ar groups is substituted with at least one C.sub.1 - C.sub.5 alkoxy, C.sub.1 - C.sub.5 alkyl groups or mixtures thereof.
- 5. A method of inhibiting activity and suppressing activation of thrombin in vivo which comprises administering to a mammal a pharmaceutically effective amount of a compound of claim 1.
- 6. A method of inhibiting activity and suppressing activation of thrombin in vivo which comprises administering to a mammal a pharmaceutically effective amount of a compound of claim 2.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of the following applications:
Application Ser. No. 671,436 and Ser. No. 671,568 are divisional applications of Ser. No. 622,390 of Oct. 14, 1975 now abandoned.
US Referenced Citations (5)
Number |
Name |
Date |
Kind |
3131174 |
Schwyzer |
Apr 1964 |
|
4018913 |
Okamoto, et al. |
Apr 1977 |
|
4018915 |
Okamoto, et al. |
Apr 1977 |
|
4036955 |
Okamoto, et al. |
Jul 1977 |
|
4036955 |
Okanoto, et al. |
Jul 1977 |
|
Related Publications (5)
|
Number |
Date |
Country |
|
723474 |
Sep 1976 |
|
|
728051 |
Sep 1976 |
|
|
671436 |
Mar 1976 |
|
|
671568 |
Mar 1976 |
|
|
671568 |
|
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
622390 |
Oct 1975 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
707536 |
Jul 1976 |
|